1-27914142-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002946.5(RPA2):c.38C>T(p.Ser13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,613,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002946.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPA2 | NM_002946.5 | c.38C>T | p.Ser13Leu | missense_variant | 2/9 | ENST00000373912.8 | NP_002937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPA2 | ENST00000373912.8 | c.38C>T | p.Ser13Leu | missense_variant | 2/9 | 1 | NM_002946.5 | ENSP00000363021 | P1 | |
RPA2 | ENST00000313433.11 | c.302C>T | p.Ser101Leu | missense_variant | 1/8 | 1 | ENSP00000363015 | |||
RPA2 | ENST00000373909.7 | c.62C>T | p.Ser21Leu | missense_variant | 2/9 | 3 | ENSP00000363017 | |||
RPA2 | ENST00000444045.1 | c.50C>T | p.Ser17Leu | missense_variant | 2/6 | 5 | ENSP00000387649 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151460Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 250344Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135552
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461460Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727032
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151578Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74102
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 07, 2022 | The c.38C>T (p.S13L) alteration is located in exon 2 (coding exon 2) of the RPA2 gene. This alteration results from a C to T substitution at nucleotide position 38, causing the serine (S) at amino acid position 13 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at